Correlation Between RenovoRx and ADMA Biologics
Can any of the company-specific risk be diversified away by investing in both RenovoRx and ADMA Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining RenovoRx and ADMA Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between RenovoRx and ADMA Biologics, you can compare the effects of market volatilities on RenovoRx and ADMA Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in RenovoRx with a short position of ADMA Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of RenovoRx and ADMA Biologics.
Diversification Opportunities for RenovoRx and ADMA Biologics
0.57 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between RenovoRx and ADMA is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding RenovoRx and ADMA Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ADMA Biologics and RenovoRx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on RenovoRx are associated (or correlated) with ADMA Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ADMA Biologics has no effect on the direction of RenovoRx i.e., RenovoRx and ADMA Biologics go up and down completely randomly.
Pair Corralation between RenovoRx and ADMA Biologics
Given the investment horizon of 90 days RenovoRx is expected to generate 1.41 times less return on investment than ADMA Biologics. In addition to that, RenovoRx is 1.89 times more volatile than ADMA Biologics. It trades about 0.07 of its total potential returns per unit of risk. ADMA Biologics is currently generating about 0.19 per unit of volatility. If you would invest 381.00 in ADMA Biologics on August 27, 2024 and sell it today you would earn a total of 1,737 from holding ADMA Biologics or generate 455.91% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
RenovoRx vs. ADMA Biologics
Performance |
| Timeline |
| RenovoRx |
| ADMA Biologics |
RenovoRx and ADMA Biologics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with RenovoRx and ADMA Biologics
The main advantage of trading using opposite RenovoRx and ADMA Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if RenovoRx position performs unexpectedly, ADMA Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ADMA Biologics will offset losses from the drop in ADMA Biologics' long position.| RenovoRx vs. Eliem Therapeutics | RenovoRx vs. HCW Biologics | RenovoRx vs. Scpharmaceuticals | RenovoRx vs. Milestone Pharmaceuticals |
| ADMA Biologics vs. Atara Biotherapeutics | ADMA Biologics vs. Fate Therapeutics | ADMA Biologics vs. Sana Biotechnology | ADMA Biologics vs. Caribou Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |